Showing 20,581 - 20,600 results of 21,342 for search '(( significance ((we decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.64s Refine Results
  1. 20581

    Data_Sheet_2_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. …”
  2. 20582

    Table 2_Modified maxillomandibular advancement for Eastern Asian patients with moderate or severe OSA: an anatomic and aerodynamic assessment of the upper airway.xlsx by Kan Li (490394)

    Published 2025
    “…The apnea–hypopnea index (36.05 ± 17.68 vs. 5.72 ± 4.76, p < 0.001) and the ESS (13.23 ± 8.9 vs. 6.23 ± 6.81 events/h, p < 0.05) decreased significantly, while the lowest oxygen saturation (76.54 ± 10.26% vs. 84.77 ± 6.02%, p < 0.05) improved greatly. …”
  3. 20583

    Table_2_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. …”
  4. 20584

    Table 1_Modified maxillomandibular advancement for Eastern Asian patients with moderate or severe OSA: an anatomic and aerodynamic assessment of the upper airway.xlsx by Kan Li (490394)

    Published 2025
    “…The apnea–hypopnea index (36.05 ± 17.68 vs. 5.72 ± 4.76, p < 0.001) and the ESS (13.23 ± 8.9 vs. 6.23 ± 6.81 events/h, p < 0.05) decreased significantly, while the lowest oxygen saturation (76.54 ± 10.26% vs. 84.77 ± 6.02%, p < 0.05) improved greatly. …”
  5. 20585

    Table_3_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. …”
  6. 20586

    Data Sheet 1_The effects and mechanism of urease inhibitor and its combination with nitrification inhibitor on nitrous oxide emission across four soil types.docx by Churong Liu (11174070)

    Published 2025
    “…<p>Nitrogen (N) fertilization is essential for ensuring crop productivity, while excessive N application significantly increases greenhouse gases (GHGs) emissions, particularly nitrous oxide (N<sub>2</sub>O). …”
  7. 20587

    Table_1_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. …”
  8. 20588

    Data_Sheet_1_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. …”
  9. 20589

    Baseline characteristics of participants. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  10. 20590

    The framework diagram of this study. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  11. 20591

    Table 1_Exploring the alleviating effects of Bifidobacterium metabolite lactic acid on non-alcoholic steatohepatitis through the gut-liver axis.docx by Hongmei Zhao (250090)

    Published 2025
    “…</p>Results<p>In vivo findings indicated that, in comparison to CBX group (Control group without antibiotic treatment), NAFLD/CBX group (NAFLD group without antibiotic administration) and NAFLD/ABX group (NAFLD group with antibiotic administration) exhibited increased liver-to-body weight ratio, higher lipid droplet accumulation, aggravated liver histopathological damage, and elevated levels of AST (Aspartate Aminotransferase), ALT (Alanine Aminotransferase), TC (Total Cholesterol), TG (Triglycerides), LDL-C (Low-Density Lipoprotein Cholesterol), IL-6 (Interleukin-6), TNF-α (Tumor Necrosis Factor-alpha), IL-1β (Interleukin-1 beta), and NLRP3-related molecules, while HDL-C (High-Density Lipoprotein Cholesterol) levels significantly decreased. Intervention with Bifidobacterium significantly reversed these adverse changes. …”
  12. 20592

    Data Sheet 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  13. 20593

    Data Sheet 3_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  14. 20594

    Table 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.xls by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  15. 20595

    Image 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.jpeg by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  16. 20596

    Data Sheet 5_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  17. 20597

    Data Sheet 2_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  18. 20598

    Data Sheet 8_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  19. 20599

    Data Sheet 6_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  20. 20600

    Data Sheet 7_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”